10X Genomics Inc (NASDAQ:TXG)
| 155.94 Delayed Data As of Mar 05 |  +8.54 / +5.79%Today’s Change | 48.78 Today|||52-Week Range 201.70 | +10.13% Year-to-Date |
Latest TXG News | Press Releases
| Baron Perspective- 2020: A Year We Will Remember Mar 01 / GuruFocus News - Paid Partner Content | Better Buy: iShares Russell 2000 Growth ETF vs Schwab U.S. Small-Cap ETF Feb 28 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 147.40 |
| Today’s open | 171.54 |
| Day’s range | 140.81 - 156.89 |
| Volume | 99,420 |
| Average volume (3 months) | 769,992 |
| Market cap | $16.9B |
Data as of 3:59pm ET, 03/05/2021
Growth & Valuation
| Earnings growth (last year) | -1,552.45% |
| Earnings growth (this year) | +81.72% |
| Earnings growth (next 5 years) | -109.13% |
| Revenue growth (last year) | +21.53% |
| P/E ratio | NM |
| Price/Sales | 47.93 |
| Price/Book | 22.84 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 17, 2021 |
| EPS forecast (this quarter) | -$0.28 |
| Annual revenue (last year) | $298.8M |
| Annual profit (last year) | -$542.7M |
| Net profit margin | -181.61% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
